VTVT - vTv Therapeutics GAAP EPS of -$0.05 November, 10 2022 05:44 PM vTv Therapeutics Inc. vTv Therapeutics press release ( NASDAQ: VTVT ): Q3 GAAP EPS of -$0.05. The Company’s cash position as of September 30, 2022, was $15.3 million compared to $13.4 million as of December 31, 2021. For further details see: vTv Therapeutics GAAP EPS of -$0.05